Results 11 to 20 of about 7,305,993 (392)
Journal of Experimental Medicine, 1963 Injection of a sufficient dose of bacteriophage φX 174 into guinea pigs results in the formation of rapidly sedimenting antibody molecules (19S), and later, slowly sedimenting molecules (7S).
Jonathan W. Uhr, Martin S. Finkelstein
openalex +2 more sources
THE DISTRIBUTION OF ANTIBODIES AND THEIR FORMATION BY THE BLOOD [PDF]
Journal of Infectious Diseases, 1910 In the following we give a brief summary of the principal results that we have obtained from a study of the distribution of antibodies in the body fluids of dogs and of their formation by the blood. The complete article will be published later. In active immunization of dogs by a single intravenous injection of goat blood the lysin, agglutinin and ...
L. Hektoen
openalex +8 more sources
The Journal of Experimental Medicine, 1961 The suppression of antibody formation by passively administered antibody is influenced by the dose and nature of the antigen, type of immunization procedure, ratio of antibody to antigen, species origin and characteristics of the antiserum used, as well as the species selected for immunization.
Jonathan W. Uhr, Joyce B. Baumann
openalex +8 more sources
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19 [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are ...
Hye Hee Cha +6 more
doaj +1 more source
Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19 [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19 ...
Ji Yeun Kim +5 more
doaj +1 more source
Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness [PDF]
Vojnosanitetski Pregled, 2022 Background/Aim. Plasma containing a high titer of anti-SARS-CoV-2 antibodies, donated from individuals who recovered from COVID-19, has the potential to be used as initial therapy for patients who have been infected (passive immunization).
Grujić Jasmina +4 more
doaj +1 more source
Antibody Formation in the Rat [PDF]
The Journal of Immunology, 1962 Summary The role of a) dose of antigen, b) the route of its injection, and c) presence or absence of the spleen in the primary and secondary agglutinin response of the rat have been studied using purified particulate flagella from Salmonella typhosa as antigen.
Frank W. Fitch, James Winebright
+5 more sources
Humoral response to viral vector COVID-19 vaccine in hemodialysis patients [PDF]
Kidney Research and Clinical Practice, 2022 Background The coronavirus disease 2019 (COVID-19) vaccine is not readily available in many countries where dosing interval is spaced more than ideal. Patients with chronic kidney disease, especially those on maintenance hemodialysis, have a tendency for
Niranjan Raja +5 more
doaj +1 more source
Frontiers in Immunology, 2021 Predicted Indirectly ReCognizable Human Leukocyte Antigen (HLA) Epitopes (PIRCHE) are known to be a significant risk factor for the development of donor HLA-specific antibodies after organ transplantation.
Matthias Niemann +8 more
doaj +1 more source
Therapies for Chronic Allograft Rejection
Frontiers in Pharmacology, 2021 Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes.
Min Young Kim, Daniel C. Brennan
doaj +1 more source